OPKO Health ROE 2010-2023 | OPK
OPKO Health ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2023-12-31 | $-0.19B | $1.39B | -12.70% |
2023-09-30 | $-0.21B | $1.45B | -13.59% |
2023-06-30 | $-0.21B | $1.54B | -13.32% |
2023-03-31 | $-0.29B | $1.55B | -18.01% |
2022-12-31 | $-0.33B | $1.56B | -20.11% |
2022-09-30 | $-0.32B | $1.63B | -19.07% |
2022-06-30 | $-0.20B | $1.72B | -11.91% |
2022-03-31 | $-0.12B | $1.62B | -6.81% |
2021-12-31 | $-0.03B | $1.69B | -1.74% |
2021-09-30 | $0.08B | $1.77B | 4.42% |
2021-06-30 | $0.07B | $1.74B | 4.22% |
2021-03-31 | $0.12B | $1.70B | 7.35% |
2020-12-31 | $0.03B | $1.67B | 1.93% |
2020-09-30 | $-0.11B | $1.62B | -7.09% |
2020-06-30 | $-0.20B | $1.59B | -12.45% |
2020-03-31 | $-0.29B | $1.55B | -17.99% |
2019-12-31 | $-0.32B | $1.62B | -18.72% |
2019-09-30 | $-0.28B | $1.64B | -16.16% |
2019-06-30 | $-0.25B | $1.71B | -13.90% |
2019-03-31 | $-0.19B | $1.76B | -10.68% |
2018-12-31 | $-0.15B | $1.79B | -8.48% |
2018-09-30 | $-0.30B | $1.79B | -16.24% |
2018-06-30 | $-0.30B | $1.81B | -16.02% |
2018-03-31 | $-0.31B | $1.82B | -15.97% |
2017-12-31 | $-0.31B | $1.84B | -15.02% |
2017-09-30 | $-0.13B | $2.09B | -5.96% |
2017-06-30 | $-0.10B | $2.11B | -4.95% |
2017-03-31 | $-0.07B | $2.11B | -3.41% |
2016-12-31 | $-0.05B | $2.09B | -2.34% |
2016-09-30 | $-0.01B | $2.11B | -0.44% |
2016-06-30 | $0.13B | $2.02B | 6.73% |
2016-03-31 | $0.08B | $2.00B | 4.43% |
2015-12-31 | $-0.03B | $1.98B | -2.15% |
2015-09-30 | $-0.09B | $1.97B | -7.65% |
2015-06-30 | $-0.26B | $0.83B | -31.16% |
2015-03-31 | $-0.24B | $0.81B | -28.30% |
2014-12-31 | $-0.17B | $0.84B | -19.84% |
2014-09-30 | $-0.14B | $0.89B | -15.53% |
2014-06-30 | $-0.15B | $0.91B | -16.87% |
2014-03-31 | $-0.13B | $0.83B | -17.34% |
2013-12-31 | $-0.12B | $0.87B | -19.38% |
2013-09-30 | $-0.10B | $0.87B | -23.59% |
2013-06-30 | $-0.05B | $0.31B | -20.48% |
2013-03-31 | $-0.06B | $0.32B | -28.61% |
2012-12-31 | $-0.03B | $0.18B | -19.62% |
2012-09-30 | $-0.01B | $0.15B | -7.82% |
2012-06-30 | $-0.01B | $0.15B | -7.72% |
2012-03-31 | $-0.01B | $0.16B | -4.54% |
2011-12-31 | $-0.00B | $0.16B | -2.41% |
2011-09-30 | $-0.02B | $0.10B | -24.44% |
2011-06-30 | $-0.02B | $0.11B | -30.22% |
2011-03-31 | $-0.02B | $0.12B | -40.55% |
2010-12-31 | $-0.02B | $0.02B | -56.38% |
2010-09-30 | $-0.03B | $0.02B | -75.95% |
2010-06-30 | $-0.03B | $0.05B | -63.37% |
2010-03-31 | $-0.03B | $0.06B | -64.92% |
2009-12-31 | $-0.04B | $0.03B | -110.24% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.857B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $209.324B | 25.46 |
Intuitive Surgical (ISRG) | United States | $130.862B | 78.83 |
Edwards Lifesciences (EW) | United States | $52.344B | 34.65 |
DexCom (DXCM) | United States | $50.703B | 87.10 |
IQVIA Holdings (IQV) | United States | $41.988B | 24.90 |
IDEXX Laboratories (IDXX) | United States | $39.830B | 47.62 |
Alcon (ALC) | Switzerland | $39.749B | 29.31 |
STERIS (STE) | Ireland | $19.852B | 23.50 |
Hologic (HOLX) | United States | $17.891B | 19.75 |
Waters (WAT) | United States | $17.747B | 25.47 |
SONOVA HOLDING (SONVY) | Switzerland | $16.624B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.289B | 84.91 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.059B | 14.89 |
Sysmex ADR (SSMXY) | Japan | $9.956B | 31.22 |
Teleflex (TFX) | United States | $9.763B | 15.33 |
Penumbra (PEN) | United States | $7.857B | 97.13 |
Masimo (MASI) | United States | $7.107B | 39.86 |
Globus Medical (GMED) | United States | $6.938B | 22.00 |
Glaukos (GKOS) | United States | $4.966B | 0.00 |
Integer Holdings (ITGR) | United States | $3.908B | 24.98 |
LivaNova (LIVN) | United Kingdom | $2.914B | 19.22 |
TransMedics (TMDX) | United States | $2.830B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.660B | 18.25 |
PROCEPT BioRobotics (PRCT) | United States | $2.609B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
Integra LifeSciences Holdings (IART) | United States | $2.278B | 9.35 |
Inari Medical (NARI) | United States | $2.198B | 379.30 |
Tandem Diabetes Care (TNDM) | United States | $2.049B | 0.00 |
RxSight (RXST) | United States | $1.936B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.765B | 0.00 |
Veracyte (VCYT) | United States | $1.490B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.876B | 16.20 |
Artivion (AORT) | United States | $0.837B | 96.76 |
Paragon 28 (FNA) | United States | $0.812B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.685B | 0.00 |
Silk Road Medical (SILK) | United States | $0.682B | 0.00 |
SiBone (SIBN) | United States | $0.639B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.552B | 18.73 |
IRadimed (IRMD) | United States | $0.536B | 31.15 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.489B | 0.00 |
Nevro (NVRO) | United States | $0.450B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.418B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.378B | 0.00 |
NeuroPace (NPCE) | United States | $0.368B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.348B | 11.72 |
CVRx (CVRX) | United States | $0.317B | 0.00 |
AxoGen (AXGN) | United States | $0.300B | 0.00 |
Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
Accuray (ARAY) | United States | $0.215B | 0.00 |
Semler Scientific (SMLR) | United States | $0.185B | 9.95 |
908 Devices (MASS) | United States | $0.184B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.178B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.170B | 0.00 |
Inogen (INGN) | United States | $0.158B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
Delcath Systems (DCTH) | United States | $0.140B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
Neuronetics (STIM) | United States | $0.112B | 0.00 |
Envoy Medical (COCH) | United States | $0.099B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.097B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
Hyperfine (HYPR) | United States | $0.061B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.057B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.056B | 113.00 |
Vasomedical (VASO) | United States | $0.051B | 9.17 |
Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
InspireMD (NSPR) | Israel | $0.045B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.039B | 0.00 |
LENSAR (LNSR) | United States | $0.037B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.036B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.033B | 0.00 |
Spectral AI (MDAI) | United States | $0.032B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
PAVmed (PAVM) | United States | $0.017B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.005B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |